Edatrexate
Alternative Names: 10 EDAM; CGP 30694Latest Information Update: 17 Aug 2007
At a glance
- Originator Memorial Sloan-Kettering Cancer Center; SRI International
- Developer SRI International
- Class Antineoplastics; Pterins; Small molecules
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer; Rheumatoid arthritis